PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.\', \'Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.\', \'Universidad de Córdoba, Montería, Córdoba, Colombia.\', \'Universidad Del Sinú, Montería, Córdoba, Colombia.\', \'Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.\', \'Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.\', \'Department of Emergency Medicine, New York University Grossman School of Medicine, New York, NY, USA.\', \'Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA ana.rodriguez@nyumc.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • e20210118010.26508/lsa.202101180
?:doi
?:hasPublicationType
?:journal
  • Life science alliance
is ?:pmid of
?:pmid
?:pmid
  • 34504035
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all